nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofarabine—ABCG2—Dexamethasone—psoriatic arthritis	0.0622	0.554	CbGbCtD
Clofarabine—ABCG2—Methotrexate—psoriatic arthritis	0.05	0.446	CbGbCtD
Clofarabine—DCK—Desoximetasone—Methylprednisolone—psoriatic arthritis	0.00308	0.0885	CbGdCrCtD
Clofarabine—DCK—Desoximetasone—Betamethasone—psoriatic arthritis	0.00303	0.0871	CbGdCrCtD
Clofarabine—DCK—Desoximetasone—Dexamethasone—psoriatic arthritis	0.00303	0.0871	CbGdCrCtD
Clofarabine—DCK—Diflorasone—Methylprednisolone—psoriatic arthritis	0.00299	0.0859	CbGdCrCtD
Clofarabine—DCK—Desoximetasone—Triamcinolone—psoriatic arthritis	0.00296	0.0851	CbGdCrCtD
Clofarabine—DCK—Diflorasone—Dexamethasone—psoriatic arthritis	0.00294	0.0846	CbGdCrCtD
Clofarabine—DCK—Diflorasone—Betamethasone—psoriatic arthritis	0.00294	0.0846	CbGdCrCtD
Clofarabine—DCK—Diflorasone—Triamcinolone—psoriatic arthritis	0.00287	0.0826	CbGdCrCtD
Clofarabine—DCK—Desoximetasone—Prednisone—psoriatic arthritis	0.00281	0.0808	CbGdCrCtD
Clofarabine—DCK—Desoximetasone—Prednisolone—psoriatic arthritis	0.00274	0.0789	CbGdCrCtD
Clofarabine—DCK—Diflorasone—Prednisone—psoriatic arthritis	0.00272	0.0784	CbGdCrCtD
Clofarabine—DCK—Diflorasone—Prednisolone—psoriatic arthritis	0.00266	0.0765	CbGdCrCtD
Clofarabine—Haemoglobin—Betamethasone—psoriatic arthritis	0.00191	0.00224	CcSEcCtD
Clofarabine—Haemoglobin—Dexamethasone—psoriatic arthritis	0.00191	0.00224	CcSEcCtD
Clofarabine—Irritability—Methotrexate—psoriatic arthritis	0.00191	0.00224	CcSEcCtD
Clofarabine—Haemorrhage—Dexamethasone—psoriatic arthritis	0.0019	0.00223	CcSEcCtD
Clofarabine—Haemorrhage—Betamethasone—psoriatic arthritis	0.0019	0.00223	CcSEcCtD
Clofarabine—Angiopathy—Methylprednisolone—psoriatic arthritis	0.0019	0.00222	CcSEcCtD
Clofarabine—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.00189	0.00222	CcSEcCtD
Clofarabine—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.00189	0.00221	CcSEcCtD
Clofarabine—Weight decreased—Prednisone—psoriatic arthritis	0.00187	0.0022	CcSEcCtD
Clofarabine—Mental disorder—Methylprednisolone—psoriatic arthritis	0.00183	0.00215	CcSEcCtD
Clofarabine—Erythema—Triamcinolone—psoriatic arthritis	0.00183	0.00214	CcSEcCtD
Clofarabine—Malnutrition—Methylprednisolone—psoriatic arthritis	0.00182	0.00213	CcSEcCtD
Clofarabine—Erythema—Methylprednisolone—psoriatic arthritis	0.00182	0.00213	CcSEcCtD
Clofarabine—Neuropathy peripheral—Prednisone—psoriatic arthritis	0.00181	0.00212	CcSEcCtD
Clofarabine—Toxic epidermal necrolysis—Methotrexate—psoriatic arthritis	0.0018	0.00211	CcSEcCtD
Clofarabine—Back pain—Triamcinolone—psoriatic arthritis	0.00177	0.00207	CcSEcCtD
Clofarabine—Angiopathy—Dexamethasone—psoriatic arthritis	0.00173	0.00202	CcSEcCtD
Clofarabine—Angiopathy—Betamethasone—psoriatic arthritis	0.00173	0.00202	CcSEcCtD
Clofarabine—Hypertension—Prednisolone—psoriatic arthritis	0.00171	0.00201	CcSEcCtD
Clofarabine—Pancreatitis—Methotrexate—psoriatic arthritis	0.0017	0.00199	CcSEcCtD
Clofarabine—Alopecia—Dexamethasone—psoriatic arthritis	0.00168	0.00197	CcSEcCtD
Clofarabine—Alopecia—Betamethasone—psoriatic arthritis	0.00168	0.00197	CcSEcCtD
Clofarabine—Haemoglobin—Prednisone—psoriatic arthritis	0.00167	0.00195	CcSEcCtD
Clofarabine—Haemorrhage—Prednisone—psoriatic arthritis	0.00166	0.00194	CcSEcCtD
Clofarabine—Erythema—Betamethasone—psoriatic arthritis	0.00166	0.00194	CcSEcCtD
Clofarabine—Erythema—Dexamethasone—psoriatic arthritis	0.00166	0.00194	CcSEcCtD
Clofarabine—Pancytopenia—Methotrexate—psoriatic arthritis	0.00164	0.00193	CcSEcCtD
Clofarabine—Connective tissue disorder—Prednisone—psoriatic arthritis	0.00163	0.00191	CcSEcCtD
Clofarabine—Oedema—Prednisolone—psoriatic arthritis	0.00162	0.0019	CcSEcCtD
Clofarabine—Neutropenia—Methotrexate—psoriatic arthritis	0.00162	0.0019	CcSEcCtD
Clofarabine—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.00161	0.00188	CcSEcCtD
Clofarabine—Cough—Triamcinolone—psoriatic arthritis	0.00159	0.00187	CcSEcCtD
Clofarabine—Tachycardia—Prednisolone—psoriatic arthritis	0.00158	0.00185	CcSEcCtD
Clofarabine—Hypertension—Triamcinolone—psoriatic arthritis	0.00158	0.00185	CcSEcCtD
Clofarabine—Hypertension—Methylprednisolone—psoriatic arthritis	0.00157	0.00184	CcSEcCtD
Clofarabine—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00157	0.00184	CcSEcCtD
Clofarabine—Myalgia—Triamcinolone—psoriatic arthritis	0.00155	0.00182	CcSEcCtD
Clofarabine—Pneumonia—Methotrexate—psoriatic arthritis	0.00155	0.00182	CcSEcCtD
Clofarabine—Myalgia—Methylprednisolone—psoriatic arthritis	0.00155	0.00182	CcSEcCtD
Clofarabine—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00155	0.00182	CcSEcCtD
Clofarabine—Anxiety—Methylprednisolone—psoriatic arthritis	0.00155	0.00181	CcSEcCtD
Clofarabine—Infestation—Methotrexate—psoriatic arthritis	0.00154	0.00181	CcSEcCtD
Clofarabine—Infestation NOS—Methotrexate—psoriatic arthritis	0.00154	0.00181	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00154	0.0018	CcSEcCtD
Clofarabine—Flushing—Prednisone—psoriatic arthritis	0.00154	0.0018	CcSEcCtD
Clofarabine—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.00153	0.00179	CcSEcCtD
Clofarabine—Renal failure—Methotrexate—psoriatic arthritis	0.00152	0.00178	CcSEcCtD
Clofarabine—Stomatitis—Methotrexate—psoriatic arthritis	0.0015	0.00176	CcSEcCtD
Clofarabine—Angiopathy—Prednisone—psoriatic arthritis	0.0015	0.00176	CcSEcCtD
Clofarabine—Immune system disorder—Prednisone—psoriatic arthritis	0.0015	0.00175	CcSEcCtD
Clofarabine—Oedema—Triamcinolone—psoriatic arthritis	0.00149	0.00175	CcSEcCtD
Clofarabine—Infection—Triamcinolone—psoriatic arthritis	0.00148	0.00173	CcSEcCtD
Clofarabine—Infection—Methylprednisolone—psoriatic arthritis	0.00148	0.00173	CcSEcCtD
Clofarabine—Haematuria—Methotrexate—psoriatic arthritis	0.00147	0.00172	CcSEcCtD
Clofarabine—Alopecia—Prednisone—psoriatic arthritis	0.00146	0.00172	CcSEcCtD
Clofarabine—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.00146	0.00171	CcSEcCtD
Clofarabine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00146	0.00171	CcSEcCtD
Clofarabine—Epistaxis—Methotrexate—psoriatic arthritis	0.00145	0.00171	CcSEcCtD
Clofarabine—Paraesthesia—Prednisolone—psoriatic arthritis	0.00145	0.00171	CcSEcCtD
Clofarabine—Tachycardia—Triamcinolone—psoriatic arthritis	0.00145	0.0017	CcSEcCtD
Clofarabine—Mental disorder—Prednisone—psoriatic arthritis	0.00145	0.0017	CcSEcCtD
Clofarabine—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00145	0.0017	CcSEcCtD
Clofarabine—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00144	0.00169	CcSEcCtD
Clofarabine—Malnutrition—Prednisone—psoriatic arthritis	0.00144	0.00169	CcSEcCtD
Clofarabine—Erythema—Prednisone—psoriatic arthritis	0.00144	0.00169	CcSEcCtD
Clofarabine—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00144	0.00169	CcSEcCtD
Clofarabine—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00144	0.00168	CcSEcCtD
Clofarabine—Hypertension—Betamethasone—psoriatic arthritis	0.00143	0.00168	CcSEcCtD
Clofarabine—Hypertension—Dexamethasone—psoriatic arthritis	0.00143	0.00168	CcSEcCtD
Clofarabine—Myalgia—Betamethasone—psoriatic arthritis	0.00141	0.00165	CcSEcCtD
Clofarabine—Myalgia—Dexamethasone—psoriatic arthritis	0.00141	0.00165	CcSEcCtD
Clofarabine—Anxiety—Betamethasone—psoriatic arthritis	0.00141	0.00165	CcSEcCtD
Clofarabine—Anxiety—Dexamethasone—psoriatic arthritis	0.00141	0.00165	CcSEcCtD
Clofarabine—Haemoglobin—Methotrexate—psoriatic arthritis	0.00139	0.00163	CcSEcCtD
Clofarabine—Hypotension—Methylprednisolone—psoriatic arthritis	0.00139	0.00163	CcSEcCtD
Clofarabine—Pain—Prednisolone—psoriatic arthritis	0.00139	0.00162	CcSEcCtD
Clofarabine—Haemorrhage—Methotrexate—psoriatic arthritis	0.00138	0.00162	CcSEcCtD
Clofarabine—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.00137	0.0016	CcSEcCtD
Clofarabine—Urethral disorder—Methotrexate—psoriatic arthritis	0.00136	0.00159	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00136	0.00159	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00135	0.00159	CcSEcCtD
Clofarabine—Oedema—Betamethasone—psoriatic arthritis	0.00135	0.00158	CcSEcCtD
Clofarabine—Oedema—Dexamethasone—psoriatic arthritis	0.00135	0.00158	CcSEcCtD
Clofarabine—Infection—Dexamethasone—psoriatic arthritis	0.00134	0.00157	CcSEcCtD
Clofarabine—Infection—Betamethasone—psoriatic arthritis	0.00134	0.00157	CcSEcCtD
Clofarabine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00134	0.00157	CcSEcCtD
Clofarabine—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00133	0.00156	CcSEcCtD
Clofarabine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00133	0.00156	CcSEcCtD
Clofarabine—Anaemia—Prednisone—psoriatic arthritis	0.00133	0.00156	CcSEcCtD
Clofarabine—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00133	0.00156	CcSEcCtD
Clofarabine—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00133	0.00155	CcSEcCtD
Clofarabine—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00133	0.00155	CcSEcCtD
Clofarabine—Agitation—Prednisone—psoriatic arthritis	0.00133	0.00155	CcSEcCtD
Clofarabine—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00132	0.00155	CcSEcCtD
Clofarabine—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00132	0.00155	CcSEcCtD
Clofarabine—Tachycardia—Dexamethasone—psoriatic arthritis	0.00132	0.00155	CcSEcCtD
Clofarabine—Tachycardia—Betamethasone—psoriatic arthritis	0.00132	0.00155	CcSEcCtD
Clofarabine—Erythema multiforme—Methotrexate—psoriatic arthritis	0.00131	0.00153	CcSEcCtD
Clofarabine—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00131	0.00153	CcSEcCtD
Clofarabine—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00131	0.00153	CcSEcCtD
Clofarabine—Anorexia—Dexamethasone—psoriatic arthritis	0.00129	0.00151	CcSEcCtD
Clofarabine—Anorexia—Betamethasone—psoriatic arthritis	0.00129	0.00151	CcSEcCtD
Clofarabine—Cardiac disorder—Methotrexate—psoriatic arthritis	0.00129	0.00151	CcSEcCtD
Clofarabine—Fatigue—Triamcinolone—psoriatic arthritis	0.00128	0.00151	CcSEcCtD
Clofarabine—Fatigue—Methylprednisolone—psoriatic arthritis	0.00128	0.0015	CcSEcCtD
Clofarabine—Pain—Triamcinolone—psoriatic arthritis	0.00127	0.00149	CcSEcCtD
Clofarabine—Hypotension—Dexamethasone—psoriatic arthritis	0.00126	0.00148	CcSEcCtD
Clofarabine—Hypotension—Betamethasone—psoriatic arthritis	0.00126	0.00148	CcSEcCtD
Clofarabine—Angiopathy—Methotrexate—psoriatic arthritis	0.00126	0.00147	CcSEcCtD
Clofarabine—Immune system disorder—Methotrexate—psoriatic arthritis	0.00125	0.00147	CcSEcCtD
Clofarabine—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00125	0.00146	CcSEcCtD
Clofarabine—Hypertension—Prednisone—psoriatic arthritis	0.00125	0.00146	CcSEcCtD
Clofarabine—Chills—Methotrexate—psoriatic arthritis	0.00124	0.00146	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00123	0.00144	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00123	0.00144	CcSEcCtD
Clofarabine—Arthralgia—Prednisone—psoriatic arthritis	0.00123	0.00144	CcSEcCtD
Clofarabine—Myalgia—Prednisone—psoriatic arthritis	0.00123	0.00144	CcSEcCtD
Clofarabine—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00123	0.00144	CcSEcCtD
Clofarabine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00122	0.00144	CcSEcCtD
Clofarabine—Anxiety—Prednisone—psoriatic arthritis	0.00122	0.00143	CcSEcCtD
Clofarabine—Alopecia—Methotrexate—psoriatic arthritis	0.00122	0.00143	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00122	0.00143	CcSEcCtD
Clofarabine—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00122	0.00142	CcSEcCtD
Clofarabine—Paraesthesia—Betamethasone—psoriatic arthritis	0.00121	0.00142	CcSEcCtD
Clofarabine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00121	0.00142	CcSEcCtD
Clofarabine—Mental disorder—Methotrexate—psoriatic arthritis	0.00121	0.00142	CcSEcCtD
Clofarabine—Erythema—Methotrexate—psoriatic arthritis	0.00121	0.00141	CcSEcCtD
Clofarabine—Malnutrition—Methotrexate—psoriatic arthritis	0.00121	0.00141	CcSEcCtD
Clofarabine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00119	0.0014	CcSEcCtD
Clofarabine—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00118	0.00138	CcSEcCtD
Clofarabine—Oedema—Prednisone—psoriatic arthritis	0.00118	0.00138	CcSEcCtD
Clofarabine—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00117	0.00138	CcSEcCtD
Clofarabine—Decreased appetite—Betamethasone—psoriatic arthritis	0.00117	0.00138	CcSEcCtD
Clofarabine—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00117	0.00138	CcSEcCtD
Clofarabine—Infection—Prednisone—psoriatic arthritis	0.00117	0.00137	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00117	0.00137	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00117	0.00137	CcSEcCtD
Clofarabine—Back pain—Methotrexate—psoriatic arthritis	0.00117	0.00137	CcSEcCtD
Clofarabine—Fatigue—Dexamethasone—psoriatic arthritis	0.00117	0.00137	CcSEcCtD
Clofarabine—Fatigue—Betamethasone—psoriatic arthritis	0.00117	0.00137	CcSEcCtD
Clofarabine—Pain—Betamethasone—psoriatic arthritis	0.00116	0.00135	CcSEcCtD
Clofarabine—Pain—Dexamethasone—psoriatic arthritis	0.00116	0.00135	CcSEcCtD
Clofarabine—Nervous system disorder—Prednisone—psoriatic arthritis	0.00115	0.00135	CcSEcCtD
Clofarabine—Tachycardia—Prednisone—psoriatic arthritis	0.00115	0.00135	CcSEcCtD
Clofarabine—Skin disorder—Prednisone—psoriatic arthritis	0.00114	0.00134	CcSEcCtD
Clofarabine—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00114	0.00133	CcSEcCtD
Clofarabine—Anorexia—Prednisone—psoriatic arthritis	0.00112	0.00132	CcSEcCtD
Clofarabine—Anaemia—Methotrexate—psoriatic arthritis	0.00111	0.00131	CcSEcCtD
Clofarabine—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00111	0.00131	CcSEcCtD
Clofarabine—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00111	0.00131	CcSEcCtD
Clofarabine—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00111	0.0013	CcSEcCtD
Clofarabine—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00111	0.0013	CcSEcCtD
Clofarabine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.0011	0.00129	CcSEcCtD
Clofarabine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.0011	0.00128	CcSEcCtD
Clofarabine—Leukopenia—Methotrexate—psoriatic arthritis	0.00108	0.00126	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00107	0.00126	CcSEcCtD
Clofarabine—Dizziness—Prednisolone—psoriatic arthritis	0.00107	0.00126	CcSEcCtD
Clofarabine—Asthenia—Triamcinolone—psoriatic arthritis	0.00107	0.00125	CcSEcCtD
Clofarabine—Abdominal pain—Betamethasone—psoriatic arthritis	0.00107	0.00125	CcSEcCtD
Clofarabine—Body temperature increased—Betamethasone—psoriatic arthritis	0.00107	0.00125	CcSEcCtD
Clofarabine—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00107	0.00125	CcSEcCtD
Clofarabine—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00107	0.00125	CcSEcCtD
Clofarabine—Asthenia—Methylprednisolone—psoriatic arthritis	0.00107	0.00125	CcSEcCtD
Clofarabine—Paraesthesia—Prednisone—psoriatic arthritis	0.00106	0.00124	CcSEcCtD
Clofarabine—Pruritus—Triamcinolone—psoriatic arthritis	0.00105	0.00124	CcSEcCtD
Clofarabine—Cough—Methotrexate—psoriatic arthritis	0.00105	0.00123	CcSEcCtD
Clofarabine—Pruritus—Methylprednisolone—psoriatic arthritis	0.00105	0.00123	CcSEcCtD
Clofarabine—Myalgia—Methotrexate—psoriatic arthritis	0.00103	0.0012	CcSEcCtD
Clofarabine—Arthralgia—Methotrexate—psoriatic arthritis	0.00103	0.0012	CcSEcCtD
Clofarabine—Decreased appetite—Prednisone—psoriatic arthritis	0.00102	0.0012	CcSEcCtD
Clofarabine—Rash—Prednisolone—psoriatic arthritis	0.00102	0.0012	CcSEcCtD
Clofarabine—Dermatitis—Prednisolone—psoriatic arthritis	0.00102	0.0012	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00102	0.00119	CcSEcCtD
Clofarabine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00102	0.00119	CcSEcCtD
Clofarabine—Fatigue—Prednisone—psoriatic arthritis	0.00101	0.00119	CcSEcCtD
Clofarabine—Headache—Prednisolone—psoriatic arthritis	0.00101	0.00119	CcSEcCtD
Clofarabine—Dizziness—Triamcinolone—psoriatic arthritis	0.000985	0.00115	CcSEcCtD
Clofarabine—Dizziness—Methylprednisolone—psoriatic arthritis	0.000983	0.00115	CcSEcCtD
Clofarabine—Infection—Methotrexate—psoriatic arthritis	0.000977	0.00115	CcSEcCtD
Clofarabine—Feeling abnormal—Prednisone—psoriatic arthritis	0.00097	0.00114	CcSEcCtD
Clofarabine—Asthenia—Dexamethasone—psoriatic arthritis	0.00097	0.00114	CcSEcCtD
Clofarabine—Asthenia—Betamethasone—psoriatic arthritis	0.00097	0.00114	CcSEcCtD
Clofarabine—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000965	0.00113	CcSEcCtD
Clofarabine—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000963	0.00113	CcSEcCtD
Clofarabine—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000963	0.00113	CcSEcCtD
Clofarabine—Nausea—Prednisolone—psoriatic arthritis	0.000962	0.00113	CcSEcCtD
Clofarabine—Pruritus—Betamethasone—psoriatic arthritis	0.000956	0.00112	CcSEcCtD
Clofarabine—Pruritus—Dexamethasone—psoriatic arthritis	0.000956	0.00112	CcSEcCtD
Clofarabine—Skin disorder—Methotrexate—psoriatic arthritis	0.000955	0.00112	CcSEcCtD
Clofarabine—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000951	0.00111	CcSEcCtD
Clofarabine—Vomiting—Triamcinolone—psoriatic arthritis	0.000947	0.00111	CcSEcCtD
Clofarabine—Vomiting—Methylprednisolone—psoriatic arthritis	0.000945	0.00111	CcSEcCtD
Clofarabine—Rash—Triamcinolone—psoriatic arthritis	0.000939	0.0011	CcSEcCtD
Clofarabine—Dermatitis—Triamcinolone—psoriatic arthritis	0.000938	0.0011	CcSEcCtD
Clofarabine—Anorexia—Methotrexate—psoriatic arthritis	0.000938	0.0011	CcSEcCtD
Clofarabine—Rash—Methylprednisolone—psoriatic arthritis	0.000937	0.0011	CcSEcCtD
Clofarabine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000936	0.0011	CcSEcCtD
Clofarabine—Headache—Triamcinolone—psoriatic arthritis	0.000933	0.00109	CcSEcCtD
Clofarabine—Headache—Methylprednisolone—psoriatic arthritis	0.000931	0.00109	CcSEcCtD
Clofarabine—Body temperature increased—Prednisone—psoriatic arthritis	0.00093	0.00109	CcSEcCtD
Clofarabine—Abdominal pain—Prednisone—psoriatic arthritis	0.00093	0.00109	CcSEcCtD
Clofarabine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000925	0.00108	CcSEcCtD
Clofarabine—Diarrhoea—Betamethasone—psoriatic arthritis	0.000925	0.00108	CcSEcCtD
Clofarabine—Hypotension—Methotrexate—psoriatic arthritis	0.000919	0.00108	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000896	0.00105	CcSEcCtD
Clofarabine—Dizziness—Dexamethasone—psoriatic arthritis	0.000894	0.00105	CcSEcCtD
Clofarabine—Dizziness—Betamethasone—psoriatic arthritis	0.000894	0.00105	CcSEcCtD
Clofarabine—Nausea—Triamcinolone—psoriatic arthritis	0.000885	0.00104	CcSEcCtD
Clofarabine—Paraesthesia—Methotrexate—psoriatic arthritis	0.000883	0.00104	CcSEcCtD
Clofarabine—Nausea—Methylprednisolone—psoriatic arthritis	0.000883	0.00103	CcSEcCtD
Clofarabine—Dyspnoea—Methotrexate—psoriatic arthritis	0.000877	0.00103	CcSEcCtD
Clofarabine—Somnolence—Methotrexate—psoriatic arthritis	0.000875	0.00103	CcSEcCtD
Clofarabine—Hypersensitivity—Prednisone—psoriatic arthritis	0.000867	0.00102	CcSEcCtD
Clofarabine—Vomiting—Betamethasone—psoriatic arthritis	0.000859	0.00101	CcSEcCtD
Clofarabine—Vomiting—Dexamethasone—psoriatic arthritis	0.000859	0.00101	CcSEcCtD
Clofarabine—Decreased appetite—Methotrexate—psoriatic arthritis	0.000855	0.001	CcSEcCtD
Clofarabine—Rash—Dexamethasone—psoriatic arthritis	0.000852	0.000999	CcSEcCtD
Clofarabine—Rash—Betamethasone—psoriatic arthritis	0.000852	0.000999	CcSEcCtD
Clofarabine—Dermatitis—Betamethasone—psoriatic arthritis	0.000851	0.000998	CcSEcCtD
Clofarabine—Dermatitis—Dexamethasone—psoriatic arthritis	0.000851	0.000998	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000849	0.000996	CcSEcCtD
Clofarabine—Fatigue—Methotrexate—psoriatic arthritis	0.000848	0.000994	CcSEcCtD
Clofarabine—Headache—Betamethasone—psoriatic arthritis	0.000847	0.000993	CcSEcCtD
Clofarabine—Headache—Dexamethasone—psoriatic arthritis	0.000847	0.000993	CcSEcCtD
Clofarabine—Asthenia—Prednisone—psoriatic arthritis	0.000845	0.00099	CcSEcCtD
Clofarabine—Pain—Methotrexate—psoriatic arthritis	0.000841	0.000986	CcSEcCtD
Clofarabine—Pruritus—Prednisone—psoriatic arthritis	0.000833	0.000976	CcSEcCtD
Clofarabine—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000811	0.00095	CcSEcCtD
Clofarabine—Diarrhoea—Prednisone—psoriatic arthritis	0.000805	0.000944	CcSEcCtD
Clofarabine—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000804	0.000943	CcSEcCtD
Clofarabine—Nausea—Betamethasone—psoriatic arthritis	0.000803	0.000941	CcSEcCtD
Clofarabine—Nausea—Dexamethasone—psoriatic arthritis	0.000803	0.000941	CcSEcCtD
Clofarabine—Dizziness—Prednisone—psoriatic arthritis	0.000778	0.000912	CcSEcCtD
Clofarabine—Body temperature increased—Methotrexate—psoriatic arthritis	0.000778	0.000912	CcSEcCtD
Clofarabine—Abdominal pain—Methotrexate—psoriatic arthritis	0.000778	0.000912	CcSEcCtD
Clofarabine—Vomiting—Prednisone—psoriatic arthritis	0.000748	0.000877	CcSEcCtD
Clofarabine—Rash—Prednisone—psoriatic arthritis	0.000742	0.00087	CcSEcCtD
Clofarabine—Dermatitis—Prednisone—psoriatic arthritis	0.000741	0.000869	CcSEcCtD
Clofarabine—Headache—Prednisone—psoriatic arthritis	0.000737	0.000864	CcSEcCtD
Clofarabine—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000725	0.00085	CcSEcCtD
Clofarabine—Asthenia—Methotrexate—psoriatic arthritis	0.000706	0.000827	CcSEcCtD
Clofarabine—Nausea—Prednisone—psoriatic arthritis	0.000699	0.00082	CcSEcCtD
Clofarabine—Pruritus—Methotrexate—psoriatic arthritis	0.000696	0.000816	CcSEcCtD
Clofarabine—Diarrhoea—Methotrexate—psoriatic arthritis	0.000673	0.000789	CcSEcCtD
Clofarabine—Dizziness—Methotrexate—psoriatic arthritis	0.000651	0.000763	CcSEcCtD
Clofarabine—Vomiting—Methotrexate—psoriatic arthritis	0.000625	0.000733	CcSEcCtD
Clofarabine—Rash—Methotrexate—psoriatic arthritis	0.00062	0.000727	CcSEcCtD
Clofarabine—Dermatitis—Methotrexate—psoriatic arthritis	0.00062	0.000726	CcSEcCtD
Clofarabine—Headache—Methotrexate—psoriatic arthritis	0.000616	0.000722	CcSEcCtD
Clofarabine—Nausea—Methotrexate—psoriatic arthritis	0.000584	0.000685	CcSEcCtD
